REZUM Procedure Safety Study for Enlarged Prostate
Treatments studied
Part of Kidney & urinary clinical trials.
This trial studies the safety and effectiveness of a procedure called REZUM for treating an enlarged prostate. It uses heated water vapor to shrink extra prostate tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man (born with male sexual organs).
- You are 18 years or older.
- You are scheduled to have a REZUM procedure for an enlarged prostate.
- You do not have any known allergies to certain anesthetics or pain medicines.
- You do not have serious heart, lung, kidney, or liver problems.
- You have not used more than 6 ml of a pain reliever called Penthrox in the last 3 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a minimally invasive steam treatment for an enlarged prostate. It may help men with moderate to severe urinary symptoms who have not had prior prostate surgery.
This trial tests if a special catheter that numbs the prostate (Schelin catheter) works better than standard local anesthesia during Rezum, a steam treatment for enlarged prostate. It aims to make the procedure less painful for men with bothersome urinary symptoms.
This study tests a treatment that uses water vapor (steam) to reduce an enlarged prostate. It may help men with BPH who are already scheduled for this procedure.
This study tests a new treatment that uses water vapor (steam) to shrink an enlarged prostate. It may help men with moderate to severe urinary symptoms who have not had prior prostate surgery.
This trial tests a treatment that uses water vapor (steam) to shrink an enlarged prostate, which can make urinating difficult. It may help if your symptoms are bothersome and other treatments haven't worked or aren't right for you.
This study compares two minimally invasive heat-based treatments for enlarged prostate glands that are causing urinary symptoms. Both treatments target the middle lobe of the prostate, which often causes the most obstruction.
Hear when a new Benign Prostate Hypertrophy(BPH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.